Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on CE, PCYC, RTK and TLAB Issued by the Paragon Report

CE
Free Research Reports on CE, PCYC, RTK and TLAB Issued by the Paragon Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1009272&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwired) -- 04/22/13 -- The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Celanese Corporation (NYSE: CE) shares spiked 11.53 percent on more 3.5 times the average daily volume Friday to close at $47.10 a share. The chemical manufacturer reported adjusted earnings per share of $1.14 for the first quarter of 2013, an increase of 44.3 percent when compared to a year ago.

Find out more about Celanese including full access to the free equity report at: www.ParagonReport.com/CE

Pharmacyclics, Inc. (NASDAQ: PCYC) shares gained 3.68 percent on volume of 847,982 shares traded Friday to close at $77.52 a share. The company announced that it has completed enrollment in its first Phase III study of its leukemia treatment. Shares of Pharmacyclics have gained approximately 34 percent year-to-date.

Find out more about Pharmacyclics including full access to the free equity report at: www.ParagonReport.com/PCYC

Rentech, Inc. (NYSE: RTK) shares surged 11.79 percent on volume of 5.49 million shares traded Friday to close at $2.18 a share. The company has announced it will hold its 2013 first quarter conference call on Thursday, May 9th at 3:00 pm PDT. Shares of Rentech are down approximately 17 percent year-to-date.

Find out more about Rentech including full access to the free equity report at: www.ParagonReport.com/RTK

Tellabs, Inc. (NASDAQ: TLAB) shares gained 2.62 percent on volume of 2.72 million shares traded Friday to close at $1.96 a share. The company is expected to release results for the first quarter 2013 after market close on Thursday, April 25th. Shares of Tellabs have fallen approximately 14 percent year-to-date.

Find out more about Tellabs including full access to the free equity report at: www.ParagonReport.com/TLAB

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact